These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 35659274
1. Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism. Chen L, Song Y, Hou T, Li X, Cheng L, Li Y, Xing Y. J Exp Clin Cancer Res; 2022 Jun 03; 41(1):194. PubMed ID: 35659274 [Abstract] [Full Text] [Related]
2. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis. Zhang H, Li M, Zhang J, Shen Y, Gui Q. Drug Des Devel Ther; 2021 Jun 03; 15():1835-1849. PubMed ID: 33976535 [Abstract] [Full Text] [Related]
3. Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway. Tan X, Song X, Fan B, Li M, Zhang A, Pei L. Anticancer Drugs; 2022 Oct 01; 33(9):871-882. PubMed ID: 36136987 [Abstract] [Full Text] [Related]
4. Circ_0003998 Regulates the Progression and Docetaxel Sensitivity of DTX-Resistant Non-Small Cell Lung Cancer Cells by the miR-136-5p/CORO1C Axis. Zhang W, Song C, Ren X. Technol Cancer Res Treat; 2021 Oct 01; 20():1533033821990040. PubMed ID: 33511909 [Abstract] [Full Text] [Related]
5. Downregulation of circular RNA hsa_circ_0000735 boosts prostate cancer sensitivity to docetaxel via sponging miR-7. Gao Y, Liu J, Huan J, Che F. Cancer Cell Int; 2020 Oct 01; 20():334. PubMed ID: 32714093 [Abstract] [Full Text] [Related]
6. MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression. Wu C, Miao C, Tang Q, Zhou X, Xi P, Chang P, Hua L, Ni H. J Cell Mol Med; 2020 Feb 01; 24(3):2098-2108. PubMed ID: 31876385 [Abstract] [Full Text] [Related]
7. Overexpression of claspin promotes docetaxel resistance and is associated with prostate-specific antigen recurrence in prostate cancer. Babasaki T, Sentani K, Sekino Y, Kobayashi G, Thang Pham Q, Katsuya N, Akabane S, Taniyama D, Hayashi T, Shiota M, Oue N, Teishima J, Matsubara A, Yasui W. Cancer Med; 2021 Aug 01; 10(16):5574-5588. PubMed ID: 34240817 [Abstract] [Full Text] [Related]
8. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12. Xue D, Lu H, Xu HY, Zhou CX, He XZ. J Cell Mol Med; 2018 Jun 01; 22(6):3223-3237. PubMed ID: 29633510 [Abstract] [Full Text] [Related]
9. Hsa_circ_0006404 and hsa_circ_0000735 Regulated Ovarian Cancer Response to Docetaxel Treatment via Regulating p-GP Expression. Chen YY, Tai YC. Biochem Genet; 2022 Feb 01; 60(1):395-414. PubMed ID: 34255218 [Abstract] [Full Text] [Related]
10. Silencing of circDPP4 suppresses cell progression of human prostate cancer and enhances docetaxel cytotoxicity through regulating the miR-564/ZIC2 axis. Gu H, Duan Z. J Gene Med; 2022 Mar 01; 24(3):e3403. PubMed ID: 34904327 [Abstract] [Full Text] [Related]
11. CircTHSD4 promotes the malignancy and docetaxel (DTX) resistance in prostate cancer by regulating miR-203/HMGA2 axis. Xie J, Lu L, Zhang J, Li Q, Chen W. Oncol Res; 2024 Mar 01; 32(3):529-544. PubMed ID: 38361751 [Abstract] [Full Text] [Related]
12. Hsa_circ_0003998 Promotes Chemoresistance via Modulation of miR-326 in Lung Adenocarcinoma Cells. Yu W, Peng W, Sha H, Li J. Oncol Res; 2019 May 07; 27(5):623-628. PubMed ID: 30764896 [Abstract] [Full Text] [Related]
13. Epigenetic activation of METTL14 promotes docetaxel resistance in prostate cancer by promoting pri-microRNA-129 maturation. Wu C, Miao C, Zhou S, Chang PA, He B, Zhou X, Tang Q. Environ Toxicol; 2024 Jun 07; 39(6):3734-3745. PubMed ID: 38546343 [Abstract] [Full Text] [Related]
14. Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA. Mao S, Zhang W, Yang F, Guo Y, Wang H, Wu Y, Wang R, Maskey N, Zheng Z, Li C, Ma W, Zhang J, Yan Y, Yao X. J Exp Clin Cancer Res; 2021 Oct 25; 40(1):336. PubMed ID: 34696782 [Abstract] [Full Text] [Related]
15. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. Yu YZ, Lv DJ, Wang C, Song XL, Xie T, Wang T, Li ZM, Guo JD, Fu DJ, Li KJ, Wu DL, Chan FL, Feng NH, Chen ZS, Zhao SC. Mol Cancer; 2022 Jan 05; 21(1):12. PubMed ID: 34986849 [Abstract] [Full Text] [Related]
16. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization. Li Y, Zhang B, Xiang L, Xia S, Kucuk O, Deng X, Boise LH, Dong JT. Theranostics; 2020 Jan 05; 10(17):7656-7670. PubMed ID: 32685011 [Abstract] [Full Text] [Related]
17. CircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9. Zhang Y, Liu F, Feng Y, Xu X, Wang Y, Zhu S, Dong J, Zhao S, Xu B, Feng N. Cancer Gene Ther; 2022 Nov 05; 29(11):1731-1741. PubMed ID: 35760899 [Abstract] [Full Text] [Related]
18. Prostate cancer cell-derived exosomes ZNF667-AS1 reduces TGFBR1 mRNA stability to inhibit Treg expansion and DTX resistance by binding to U2AF1. Shi Z, Pu W, Li M, Aihemaitijiang M, Li S, Zhang X, Liu B, Sun M, Li J, Li Z. Mol Med; 2024 Oct 18; 30(1):179. PubMed ID: 39425009 [Abstract] [Full Text] [Related]
19. TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer. Sekino Y, Han X, Kawaguchi T, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Shiota M, Yasui W, Matsubara A. Int J Mol Sci; 2019 Aug 13; 20(16):. PubMed ID: 31412591 [Abstract] [Full Text] [Related]
20. NOTCH3 promotes docetaxel resistance of prostate cancer cells through regulating TUBB3 and MAPK signaling pathway. Sun X, Zhang Y, Xin S, Jin L, Cao Q, Wang H, Wang K, Liu X, Tang C, Li W, Li Z, Wen X, Yang G, Guo C, Liu Z, Ye L. Cancer Sci; 2024 Feb 13; 115(2):412-426. PubMed ID: 38115797 [Abstract] [Full Text] [Related] Page: [Next] [New Search]